Abstract
COVID-19 emerged in late 2019 and has rapidly spread through many countries globally. The causative SARS-CoV-2 virus was not known until recently, and there is little or no natural immunity in human populations. There is an urgent need for vaccines and drugs to combat this new pandemic. In just a few months, huge efforts and resources by government, academia, and industry have been thrown into the race to develop a vaccine. This brief review summarizes and discusses the array of technologies being applied to vaccine development, highlighting the strengths and weaknesses of the various approaches.
Funder
National Health and Medical Research Council
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference54 articles.
1. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.;D Hui;Int J Infect Dis.,2020
2. Coronavirus disease (COVID-2019) situation reports,2020
3. WHO Director-General's opening remarks at the media briefing on COVID-19 - 13 March 2020,2020
4. With record-setting speed, vaccinemakers take their first shots at the new coronavirus.;J Cohen;Science.,2020
5. Draft landscape of Covid-19 candidate vaccines,2020
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献